These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression. He Y; Franco OE; Jiang M; Williams K; Love HD; Coleman IM; Nelson PS; Hayward SW Cancer Res; 2007 Sep; 67(17):8188-97. PubMed ID: 17804732 [TBL] [Abstract][Full Text] [Related]
5. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Barclay WW; Woodruff RD; Hall MC; Cramer SD Endocrinology; 2005 Jan; 146(1):13-8. PubMed ID: 15471963 [TBL] [Abstract][Full Text] [Related]
6. Negative control of epithelial cell proliferation by prostatic stroma. Kooistra A; König JJ; Romijn JC; Schröder FH Anticancer Res; 1991; 11(4):1495-500. PubMed ID: 1720936 [TBL] [Abstract][Full Text] [Related]
8. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336 [TBL] [Abstract][Full Text] [Related]
10. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma. Nunn SE; Peehl DM; Cohen P J Cell Physiol; 1997 May; 171(2):196-204. PubMed ID: 9130467 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400 [TBL] [Abstract][Full Text] [Related]
12. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment. Nguyen EV; Pereira BA; Lawrence MG; Ma X; Rebello RJ; Chan H; Niranjan B; Wu Y; Ellem S; Guan X; Wu J; Skhinas JN; Cox TR; Risbridger GP; Taylor RA; Lister NL; Daly RJ Mol Cell Proteomics; 2019 Jul; 18(7):1410-1427. PubMed ID: 31061140 [TBL] [Abstract][Full Text] [Related]
13. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
14. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer. Zenzmaier C; Sampson N; Plas E; Berger P Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731 [TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Planz B; Aretz HT; Wang Q; Tabatabaei S; Kirley SD; Lin CW; McDougal WS Prostate; 1999 Dec; 41(4):233-42. PubMed ID: 10544296 [TBL] [Abstract][Full Text] [Related]
16. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Bavik C; Coleman I; Dean JP; Knudsen B; Plymate S; Nelson PS Cancer Res; 2006 Jan; 66(2):794-802. PubMed ID: 16424011 [TBL] [Abstract][Full Text] [Related]
17. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study. Kooistra A; Romijn JC; Schröder FH Urol Res; 1997; 25 Suppl 2():S97-105. PubMed ID: 9144894 [TBL] [Abstract][Full Text] [Related]